20 May 2024
Biomedicines Webinar | Emerging Trends in Pathophysiology and Therapy of COVID-19, 4 June 2024

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Although the worst of the SARS CoV-2 pandemic is behind us, many questions and issues persist. Systemic manifestations due to COVID-19 infections and long COVID continue to emerge in multiple countries. There are a few new USA FDA-approved vaccines available in addition to the Moderna, Pfizer, and Johnson and Johnson ones, but vaccine effectiveness and immunologic memory appear to be limited in most patients. Therapies are available and should be incorporated into treatment plans for COVID-19 patients. Although the focus of these therapies is on hospitalized COVID-19 patients, orally delivered medications are now administered by health care providers.
This webinar will present discussions on these issues, as well as emerging trends, to understand COVID-19 infections and transmissibility more fully.
Date: 4 June 2024 at 5:00 CEST | 11:00 a.m. EDT | 11:00 p.m. CST Asia
Webinar ID: 828 4947 7200
Webinar Secretariat: journal.webinar@mdpi.com
Webinar Announcement: https://sciforum.net/event/Biomedicines-14
After registering, you will receive a confirmation email containing information on how to join the webinar.
Registrations with academic or institutional email addresses will be prioritized.
Unable to attend? Feel free to still register, and we will inform you when the recording is available.
Register now for free!
Speaker/Presentation |
Time in CEST |
Time in EDT |
Prof. Dr. Jon Suzuki |
5:00 p.m.–5:30 p.m. |
11:00 a.m.–11:30 p.m. |
Dr. Rosalinda Sorrentino |
5:30 p.m.–5:50 p.m. |
11:30 a.m.–11:50 p.m. |
Prof. Dr. Stefano D’Errico |
5:50 p.m.–6:10 p.m. |
11:50 p.m.–12:10 p.m. |
Dr. Mariana D’Alessandro |
6:10 p.m.–6:20 p.m. |
12:10 p.m.–12:20 p.m. |
Dr. Sara Gangi |
6:20 p.m.–6:30 p.m. |
12:20 p.m.–12:30 p.m. |
Q&A Session |
6:30 p.m.–6:45 p.m. |
12:30 p.m.–12:45 p.m. |
Prof. Dr. Jon Suzuki Closing of Webinar |
6:45 p.m.–6:50 p.m. |
12:45 p.m.–12:50 p.m. |
Webinar Chair and Keynote Speakers:
Relevant Special Issue:
“Emerging Trends in Pathophysiology and Therapy of COVID-19”
Guest Editors: Dr. Jon Suzuki and Dr. Miriam Ting